Paul Kim has an estimated net worth of $50.2 Million. This is based on reported shares across multiple companies, which include Fulgent Genetics, Inc., Cogent, Inc., EXAGEN INC., and JNI CORP.
2008 was Paul Kim's most active year for acquiring shares with 73 total transactions. Paul Kim's most active month to acquire stocks was the month of April. 2008 was Paul Kim's most active year for disposing of shares, totalling 148 transactions. Paul Kim's most active month to dispose stocks was the month of April. 2025 saw Paul Kim paying a total of $1,596,470.00 for 184,878 shares, this is the most they've acquired in one year. In 2005 Paul Kim cashed out on 898,785 shares for a total of $11,609,299.54, their largest year based on trade value.